HCPCS Level IIdrugActive
J1921
Inj labetalol hcl hikma, 5mg
BETOS: O1E
Effective: 2024-07-01
Description
Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Labetalol Hcl
Manufacturer
Hikma Pharmaceuticals USA Inc.
HCPCS Dosage
5 MG
Billing Units
4.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.